From a biochemical therapeutics standpoint, Relafen 750 ( Naproxen Acid) presents a fascinating case study in therapeutic action. Its mechanism of effect primarily involves the inhibition of cyclooxygenase ( COX mediators) enzymes, particularly the COX-2 isoform, leading to a reduction in the synthesis of PGE2 . This focused inhibition accounts for